long intergenic non-protein coding RNA 567Genealiases: []
Q-omics provides the consensus-scored LINC00567 profile across patient tissues and cancer cell-line models. LINC00567 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, LINC00567 is differentially expressed in 12, with the highest sampling consensus in LUAD. Additionally, LINC00567 RNA expression shows 8,325 significant gene co-expression associations, with the highest sampling consensus in HNSC. Together, these results highlight HNSC, and LUAD as cancer lineages where LINC00567 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00567 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00567 survival associations across molecular data types. LINC00567 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00567 RNA expression–survival associations across cancer types. High LINC00567 expression shows unfavorable associations in BLCA and ACC, but favorable associations in HNSC, UCEC, LUSC and BRCA. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for LINC00567 RNA expression.
This table summarizes LINC00567 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00567. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00567 shows lower tumor expression in KIRC and KICH and higher tumor expression in LUAD, HNSC, BRCA and LUSC. The LUAD box plot shows higher LINC00567 RNA expression in tumor versus normal tissue (log2 FC = +0.078, t-test p < 0.001).
This table shows molecular features associated with LINC00567 in patient tissues and cancer cell lines. In patient samples, LINC00567 shows the broadest associations at the RNA and protein expression levels, with HNSC recurring as the lineage with the largest associated feature set.
